HR. 4434In Committee
Cosmetic Supply Chain Transparency Act of 2025
Plain-English overview
What this bill does
Require FDA to track harmful nonfunctional constituents in cosmetics and impose testing disclosure and recordkeeping rules across the cosmetic supply chain
Key points
- Require FDA constituent list
- Require supplier constituent testing
- Direct FDA industry guidance
- Impose civil penalties
Current status
Where it stands
Status
In Committee
Latest action
2025-07-16 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.